Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajmg.a.38160PMID 28371242PMCID PMC5828021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated plasma oxytocin levels in children with Prader–Willi syndrome compared with healthy unrelated siblings

  2016cited by this paper
• Oxytocin promotes functional coupling between paraventricular nucleus and both sympathetic and parasympathetic cardioregulatory nuclei.

  2016cited by this paper
• The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders

  2016cited by this paper
• Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β‐Arrestin‐Independent Internalisation

  2016cited by this paper
• Cognitive and behavioural aspects of Prader–Willi syndrome

  2015cited by this paper
• An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.

  2015cited by this paper
• Pilot and feasibility studies come of age!

  2015cited by this paper
• “Not just another walking program”: Everyday Activity Supports You (EASY) model—a randomized pilot study for a parallel randomized controlled trial

  2015cited by this paper
• Increased Exposure to Rigid Routines can Lead to Increased Challenging Behavior Following Changes to Those Routines

  2015cited by this paper
• Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

  2014cited by this paper
• Clinical utility gene card for: Prader-Willi Syndrome

  2014cited by this paper
• The role of oxytocin and vasopressin in emotional and social behaviors.

  2014cited by this paper
• A double‐blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome

  2014influential reference
• Brain region-specific methylation in the promoter of the murine oxytocin receptor gene is involved in its expression regulation.

  2014cited by this paper
• Not all studies with small samples are pilot studies.

  2013cited by this paper
• Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice

  2013cited by this paper
• Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome

  2012cited by this paper
• Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus.

  2012cited by this paper
• Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

  2012cited by this paper
• Nutritional phases in Prader–Willi syndrome

  2011influential reference
• Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients

  2011influential reference
• Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.

  2011cited by this paper
• The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior.

  2010cited by this paper
• A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene.

  2010cited by this paper
• Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle".

  2009cited by this paper
• Whole genome microarray analysis of gene expression in Prader–Willi syndrome

  2007cited by this paper
• Assessment of Hyperphagia in Prader‐Willi Syndrome

  2007cited by this paper
• The Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders

  2007influential reference
• Design and analysis of pilot studies: recommendations for good practice.

  2004cited by this paper
• Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin

  2004cited by this paper
• Deficits in Social Attribution Ability in Prader–Willi Syndrome

  2004cited by this paper
• Validation of a Brief Quantitative Measure of Autistic Traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised

  2003cited by this paper
• Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases.

  1995cited by this paper
• Prader-Willi syndrome

  1989cited by this paper

• Clinical Presentation, Genetics, and Laboratory Testing with Integrated Genetic Analysis of Molecular Mechanisms in Prader–Willi and Angelman Syndromes: A Review

  2026cites this paper
• Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity

  2026cites this paper
• Oxytocin Deficiency in Childhood and Adolescence: Clinical Features, Diagnostic Challenges and Therapeutic Perspectives

  2025cites this paper
• Hypothalamic Oxytocin Neuronal Activation Induces Bipolar-Like Mood Changes in Mice in a Sex- and Dosage-Dependent Manner.

  2025cites this paper
• Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response

  2025cites this paper
• Complexity of the Hypothalamic Oxytocin System and its Involvement in Brain Functions and Diseases

  2025cites this paper
• Variant pubertal development in Prader-Willi syndrome: early and slow progression of pubarche with normal age at gonadarche

  2025cites this paper
• The beneficial impact of oregano essential oil supplementation on growth, physiological function, antioxidant activity, and immune response in Nile tilapia (Oreochromis niloticus) fingerlings under Aeromonas hydrophila stress

  2025cites this paper
• Pharmacological Aspects in the Management of Children and Adolescents with Prader–Willi Syndrome

  2025cites this paper
• The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease

  2025cites this paper
• Barriers, Limitations, and Experiences with Clinical Trials—Treatment in Rare Diseases with Prader–Willi Syndrome as an Example

  2025cites this paper
• Is Oxytocin a Contributor to Behavioral and Metabolic Features in Prader–Willi Syndrome?

  2024cites this paper
• Clinical Efficacy Landscaping in Genetic Obesity: A Meta-analysis in Prader–Willi Syndrome (PWS)

  2024cites this paper
• Management of Obesity-Related Genetic Disorders.

  2024cites this paper
• Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome.

  2024cites this paper
• Characterization of Circulating Protein Profiles in Individuals with Prader–Willi Syndrome and Individuals with Non-Syndromic Obesity

  2024cites this paper
• The gut microbiome and sociability

  2024cites this paper
• The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype

  2023cites this paper
• Management of Hyperphagia and Obesity in Prader–Willi Syndrome

  2023cites this paper
• Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity

  2023cites this paper
• Photoswitchable Probes of Oxytocin and Vasopressin

  2023cites this paper
• Management of Monogenic and Syndromic Obesity.

  2023cites this paper
• Intranasal Oxytocin in Pediatric Populations: Exploring the Potential for Reducing Irritability and Modulating Neural Responses: A Mini Review

  2023influential citation
• Hormonal Imbalances in Prader–Willi and Schaaf–Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals

  2023cites this paper
• Oxytocin’s Regulation of Thermogenesis May Be the Link to Prader–Willi Syndrome

  2023cites this paper
• Intranasal oxytocin as a treatment for obesity: safety and efficacy

  2023cites this paper
• Prader-Willi and Angelman Syndromes: Mechanisms and Management

  2023cites this paper
• Hyperphagia in Prader-Willi syndrome with obesity: From development to pharmacological treatment.

  2023cites this paper
• Pharmacological Support for the Treatment of Obesity—Present and Future

  2023cites this paper
• The Long Way of Oxytocin from the Uterus to the Heart in 70 Years from Its Discovery

  2023influential citation
• Clinical Trials in Prader–Willi Syndrome: A Review

  2023cites this paper
• Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial

  2023cites this paper
• Hypothalamic syndrome

  2022cites this paper
• Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.

  2022cites this paper
• Treatment of Acquired Hypothalamic Obesity: Now and the Future

  2022cites this paper
• Systematic Review: Emotion Dysregulation in Syndromic Causes of Intellectual and Developmental Disabilities.

  2022cites this paper
• Analysis of the hypothalamic oxytocin system and oxytocin receptor-expressing astrocytes in a mouse model of Prader-Willi syndrome

  2022cites this paper
• Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies

  2022cites this paper
• Oxytocin Therapy May Improve Eating Behaviors in Children with Single-Minded-1 Gene Mutation

  2022cites this paper
• Prader–Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment

  2022cites this paper
• Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader–Willi Syndrome

  2022cites this paper
• Do oxytocin neurones affect feeding?

  2021cites this paper
• Benefits of multidisciplinary care in Prader-Willi syndrome

  2021cites this paper
• Salivary oxytocin after play with parents predicts behavioural problems in preschool children.

  2021cites this paper
• The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader–Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial

  2021cites this paper
• Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome

  2021cites this paper
• Prader-Willi syndrome: Hormone therapies.

  2021cites this paper
• Animal models for Prader-Willi syndrome.

  2021cites this paper
• Reduced pituitary volume with relative T1 shortening correlates with behavior in Prader-Willi syndrome

  2021cites this paper
• Anti-Obesity Medication Use in Children and Adolescents with Prader–Willi Syndrome: Case Review and Literature Search

  2021cites this paper
• Suicidality and Self-Harming Behaviors in Patients with Prader-Willi Syndrome (PWS): Case Report and Literature Review

  2021cites this paper
• Syndrome de Prader-Willi

  2021cites this paper
• Hunger and Satiety Peptides: Is There a Pattern to Classify Patients with Prader-Willi Syndrome?

  2021cites this paper
• MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

  2021cites this paper
• Prader-Willi syndrome: an update on obesity and endocrine problems

  2021cites this paper
• Behavioral and Dietary Management for Adults with Prader–Willi Syndrome in a Residential Setting

  2020cites this paper
• Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin

  2020cites this paper
• Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial.

  2020cites this paper
• Pharmacotherapy in pediatric obesity: current evidence and landscape.

  2020cites this paper
• Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review.

  2020influential citation
• Behavioral and Dietary Management for Adults with Prader–Willi Syndrome in a Residential Setting

  2020cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.

  2020cites this paper
• What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders?

  2020cites this paper
• The Role of Intranasal Oxytocin on Social Cognition: an Integrative Human Lifespan Approach

  2020cites this paper
• The New Frontier in Oxytocin Physiology: The Oxytonic Contraction

  2020cites this paper
• The sociability spectrum: evidence from reciprocal genetic copy number variations

  2020cites this paper
• Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin

  2020cites this paper
• Epigenetic therapy of Prader-Willi syndrome.

  2019cites this paper
• Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review

  2019cites this paper
• Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader–Willi syndrome

  2019cites this paper
• Metabolic Effects of Oxytocin.

  2019cites this paper
• Psychopharmacology of neurobehavioral disorders.

  2019cites this paper
• Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update

  2019cites this paper
• Small molecule inhibitors of G9a reactivate the maternal PWS genes in Prader-Willi-Syndrome patient derived neural stem cells and differentiated neurons

  2019cites this paper
• Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis

  2019cites this paper
• Genetic Syndromes Presenting in Childhood Affecting Hypothalamic Function

  2019cites this paper
• Children Obesity, Glucose Tolerance, Ghrelin, and Prader Willi Syndrome

  2019cites this paper
• Prader-willi Syndrome: a Case Report

  2019cites this paper
• Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome—A Retrospective Cohort Study

  2019cites this paper
• A multidisciplinary approach to the clinical management of Prader–Willi syndrome

  2019cites this paper
• Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism

  2019cites this paper
• Behaviour and cognition in the imprinted gene disorder, Prader-Willi Syndrome (PWS)

  2019cites this paper
• Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection

  2018cites this paper
• Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.

  2018cites this paper
• Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness

  2018cites this paper
• The posterior pituitary expresses the serotonin receptor 2C.

  2018cites this paper
• Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.

  2018cites this paper
• Oxytocin and Prader-Willi Syndrome.

  2018cites this paper
• Advanced formulations for intranasal delivery of biologics

  2018cites this paper
• The potential of oxytocin for the treatment of hyperphagia in Prader-Willi Syndrome

  2018cites this paper
• Obesity management in Prader–Willi syndrome: current perspectives

  2018cites this paper
• How do hypothalamic nonapeptides shape youth's sociality? A systematic review on oxytocin, vasopressin and human socio‐emotional development

  2018cites this paper
• Cognitive development in children with Prader–Willi syndrome

  2018cites this paper
• Effects of intranasal oxytocin on satiety signaling in people with schizophrenia.

  2018cites this paper
• A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research

  2017influential citation
• Current Treatments of Prader-Willi Syndrome: A Systematic Review

  2017cites this paper
• Oxytocin and potential benefits for obesity treatment

  2017cites this paper
• GENETIC AND EPIGENETIC CAUSES OF OBESITY.

  2017cites this paper
• Review of Prader-Willi syndrome: the endocrine approach.

  2017cites this paper
• A review of clinical trials of oxytocin in Prader–Willi syndrome

  2017cites this paper